| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6174759 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2011 | 8 Pages |
Abstract
Medical regimens of mifepristone/prostaglandins were effective and safe for TOP at 10-16 weeks' gestation. Misoprostol was super than PG05, and misoprostol vaginally was found to have better effectiveness than misoprostol orally. Further research should evaluate the relative effectiveness of medical methods compared to surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Qiu-ju Chen, Shu-ping Hou, Catherine Meads, Yong-mei Huang, Qing-qing Hong, Hao-ping Zhu, Li-nan Cheng, for the EBM-CONNECT Collaboration for the EBM-CONNECT Collaboration,